Johnson & Johnson has been treading water for the past six months, recording a small loss of 3.8% while holding steady at ...

Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...

The company posted adjusted earnings of $2.77 per share on revenue of $21.9 billion, exceeding consensus estimates of $2.59 ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best low volatility stocks to buy now. The US stock market experienced a turbulent first ...

Becoming one of the first pharma majors to quantify earnings impact from the Trump administration’s newly imposed tariffs, ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other value stocks in Ken Fisher’s portfolio. Trump’s “stupid” tariffs will fail ...

Healthcare giant Johnson & Johnson (JNJ)is gearing up to release its first-quarter 2025 financials on April 15. JNJ stock has gained over ...

JOHNSON & JOHNSON ($JNJ) posted quarterly earnings results on Tuesday, April 15th. The company reported earnings of $2.77 per share, beating estimates of $2.62 by $0. ...

On the positive side, continued growth in sales of key drugs like Darzalex, along with newer products such as Erleada and ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other value stocks in Ken Fisher’s portfolio. Trump’s “stupid” tariffs will fail; that’s the sentiment ...